Pradaxa Lawsuit News: First Trials Set for August 2014
By Andrea Gressman
There is good news for the 120 plaintiffs who have filed Pradaxa lawsuits against drug manufacturer, Boehringer Ingelheim. The first Pradaxa lawsuit bellwether trials have been set to start in the beginning of August 2014. It has been reported that this is a relatively speedy turnaround because it is taking place only 2 years after the Pradaxa lawsuit MDL was originally established. It has been reported that the first Pradaxa lawsuit bellwether trials will include 4 Pradaxa lawsuits and they are expected to take place about 6 weeks apart.
What are These Bellwether Trials and Why are They So Important to the Pradaxa Lawsuit Litigation Process?
These bellwether trials are a very important part of the Pradaxa lawsuit litigation process. The Pradaxa lawsuit MDL was established to speed up the litigation process and make it more efficient. This obviously benefits the many plaintiffs seeking compensation for Pradaxa side effects, such as internal bleeding. In the Pradaxa lawsuit MDL, all of the pretrial proceedings as well as the discovery are combined, although each Pradaxa lawsuit remains separate. That way each Pradaxa lawsuit will be decided upon independently.
An important feature of the Pradaxa lawsuit MDL is the initial bellwether trials. These are a small sampling of the Pradaxa lawsuits and will be used to evaluate how the trial juries are going to typically respond to the evidence presented as well as the claims that are made.
The History of the Pradaxa Lawsuit Litigation
Pradaxa, also known as dabigitran, received its approval on October 19, 2010 by the FDA. It was approved to treat those who had non-valvular atrial fibrillation as an anticoagulant in order to reduce the patient’s risk of having a stroke due to a blood clot. However, after only 14 months on the market, reports started to pour into the FDA regarding adverse Pradaxa bleeding side effects. In fact, the FDA received over 2,367 adverse side effect reports of bleeding complications from Pradaxa. This included 542 reports of death related to Pradaxa, over 300 cases of rectal bleeding, over 900 cases of gastrointestinal bleeding, and over 200 cases of cerebrovascular accidents.
March of 2012 marked the very first filing of a Pradaxa side effects lawsuit and there have been many more to follow. In August of 2012, the U.S. Judicial Panel of Multidistrict Litigation created the Pradaxa lawsuit MDL. The MDL is now being overseen by Judge David R. Herndon in the U.S. District Court for the Southern District of Illinois.
Filing a Pradaxa Lawsuit and Joining the MDL
If you or someone you love has suffered from Pradaxa internal bleeding or a heart attack side effects, you still have time to file a Pradaxa lawsuit and join the MDL. Visit the Pradaxa Internal Bleeding Class Action Lawsuit Investigation to learn more about your legal options. Provide your information and you will receive a free consultation from a qualified Pradaxa lawsuit attorney.
Updated November 19th, 2012
All medical device, dangerous drug and medical class action and lawsuit news updates are listed in the Drug and Medical Device section of Top Class Actions.
Top Class Actions Legal Statement
